4.1 Article

Resorcylic acid lactones as new lead structures for kinase inhibition

Journal

COMPTES RENDUS CHIMIE
Volume 11, Issue 11-12, Pages 1318-1335

Publisher

ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.crci.2008.06.010

Keywords

Resorcylic acid lactone; Kinase inhibitor; Hypothemycin; LL-Z1640-2; Radicicol A; Macrolactonization; Ring-closing olefin metathesis

Ask authors/readers for more resources

The naturally occurring resorcylic acid lactones LL-Z1640-2 (1), hypothemycin (2), L-783277 (3), radicicol A (4) and, to a somewhat lesser extent, aigialomycin D (5) have recently emerged as new lead structures for kinase inhibition. Total syntheses have now been reported for all of these natural products, most of which are based on macrocyclization through ester bond formation. However, RCM-based approaches have also been described and a variety of strategies have been pursued to obtain the requisite seco acids or dienes, respectively, as precursors for macrocyclization. To cite this article: T Hofmann, K.-H. Altmann, C. R. Chimie 11 (2008). (C) 2008 Academie des sciences. Published by Elsevier Masson SAS. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.1
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available